Human or rat microsomal 5a-reductase activity, as measured by enzymic conversion of testosterone into 5a-dihydrotestosterone or by binding of a competitive inhibitor, [3H]J178-NN-diethylcarbamoyl-4-methyl-4-aza-5ca-androstan-3-one ([3H]4-MA) to the reductase, is inhibited by low concentrations (< 10 sM) of certain polyunsaturated fatty acids. The relative inhibitory potencies of unsaturated fatty acids are, in decreasing order: y-linolenic acid > cis-4,7,10,13,16,19-docosahexaenoic acid = cis-6,9,12,15-octatetraenoic acid = arachidonic acid = a-linolenic acid > linoleic acid > palmitoleic acid > oleic acid > myristoleic acid. Other unsaturated fatty acids such as undecylenic acid, erucic acid and nervonic acid, are inactive. The methyl esters and alcohol analogues of these compounds, glycerols, phospholipids, saturated fatty acids, retinoids and carotenes were inactive even at 0.2 mm. The results of the binding assay and the enzymic assay correlated well except for elaidic acid and linolelaidic acid, the trans isomers of oleic acid and linoleic acid respectively, which were much less active than their cis isomers in the binding assay but were as potent in the enzymic assay. y-Linolenic acid had no effect on the activities of two other rat liver microsomal enzymes: NADH:menadione reductase and glucuronosyl transferase. y-Linolenic acid, the most potent inhibitor tested, decreased the VmJ' and increased Km values of substrates, NADPH and testosterone, and promoted dissociation of [3H]4-MA from the microsomal reductase. y-Linolenic acid, but not the corresponding saturated fatty acid (stearic acid), inhibited the 5a-reductase activity, but not the 1 7#-dehydrogenase activity, of human prostate cancer cells in culture. These results suggest that unsaturated fatty acids may play an important role in regulating androgen action in target cells.
INTRODUCTION
In many androgen-responsive organs, such as prostate and skin, testosterone is converted into Sa-dihydrotestosterone (5a-DHT) by 5a-reductase. 5a-DHT then binds to androgen receptors and functions in the nucleus to regulate specific gene expression (Liao et al., 1989) . Since 5a-DHT promotes the development of acne, male pattern alopecia, benign prostatic hyperplasia and female hirsutism, inhibitors of 5a-reductase may be useful for treatment of these conditions. Certain 4-azasteroids are potent competitive inhibitors of Sa-reductase (Liang & Hess, 1981; Liang et al., 1984a Liang et al., , 1985a and have been shown to have therapeutic value (Vermeulen et al., 1989; Rittmaster et al., 1989; Gormley et al., 1990; Imperato-McGinley et al., 1990) . We report here that some naturally occurring unsaturated fatty acids can inhibit 5a-reductase in cultured cells and in cell-free systems. Our results suggest that these fatty acids could function as endogenous inhibitors of Sa-reductase.
MATERIALS AND METHODS Materials
Lipids, NADH, NADPH, UDP-glucuronate, carotenes, retinoids and prostaglandins, as well as detergents, polyoxyethylene ether W-1 and CHAPS were obtained from Sigma. [1,2,4,5,6,7,16,17-3H(n) ]5a-DHT (153 Ci/mmol) and [1,2,6,7-3H(n) ]testosterone (105 Ci/mmol) were products of New England Nuclear. [1,2-3H] 17fl-NN-diethylcarbamoyl-4-methyl-4-aza-Sa-androstan-3-one ([3H] 4-MA) (60 Ci/mmol) was prepared as previously described (Liang et al., 1983) . Prostate cancer cells, LNCaP and PC-3 were obtained from the American Type Culture Collection, and culture medium RPMI 1640 was from GIBCO.
Preparation of nicrosomal fractions
Microsomes were prepared at 4°C from a buffered 0.32 Msucrose homogenate of human liver and from the livers of adult Sprague-Dawley female rats by differential centrifugation as described previously (Liang et al., 1990) , and were used in the assay of 5a-reductase activity. In some experiments, microsomes were solubilized with 0.1 % polyoxyethylene ether W-l as described previously (Liang et al., 1990) , except for the substitution of polyoxyethylene ether W-1 for Lubrol-WX.
To obtain microsomal fractions that contain 5a-reductase inhibitors, rat liver microsomes (30 mg of protein) were suspended in 5 ml of 20 mM-potassium phosphate buffer, pH 7.0, mixed with 20 ml of acetic acid, and then 4 vol. of methanol were added. After 30 min, precipitated protein was removed by centrifugation at 8000 g for 10 min and the supernatant was evaporated at 50°C with a stream of nitrogen. The residue was resuspended in 1 ml of acetic acid and then centrifuged at 14000 g for 4 min. The supernatant was applied to a Sephadex G-50 column (1.5 cm x 94 cm) equilibrated with 70 % acetic acid. The column was then eluted with 70% acetic acid, and 4 ml fractions were collected. To assay 5a-reductase inhibitor activity, 0.1 ml ofeach fraction was evaporated under a stream ofnitrogen, and the residue was dissolved in 10,ul of ethanol and then combined with the [3H]4-MA binding assay mixture. Alternatively, rat liver microsomes (2.5 mg of protein) were vigorously shaken with 0.5 ml of methylene chloride at 25°C for Abbreviations used: 5a-DHT, 5az-dihydrotestosterone (17/J-hydroxy-Sa-androstan-3-one); 4-MA, 17,8-NN-diethylcarbamoyl-4-methyl-4-aza-5a-androstan-3-one. The numerical symbols for fatty acids were named according to the IUPAC-IUB recommendations [Lipids (1976) 12, [455] [456] [457] [458] [459] [460] [461] [462] [463] [464] [465] [466] [467] [468] ; for example, C183,cis-6.9,12 is the symbol for y-linolenic acid and represents the structure of a C,, unbranched fatty acid with three double bonds at positions 1 min. The methylene chloride extract was collected and the solvent was evaporated to dryness. The residue was dissolved with 0.2 ml of ethanol, and 5 ,1l of the solution was used for the assay.
13H14-MA binding assay for 5a-reductase
The procedure was described in detail previously (Liang et al., 1983 (Liang et al., , 1990 Assay of the enzymic activity of microsomal 5a-reductase
The standard reaction mixture, in a final volume of 0.15 ml, contained microsomes (1 ,tg of protein), 0.1 ,uCi of
[3H]testosterone, 0.5-3.0 /tM non-radioactive testosterone, 0.1 mM-NADPH, 1 mM-dithiothreitol and 50 mM-potassium phosphate, pH 7.0, with or without the indicated amount of a lipid. The reaction was started by the addition of microsomes and the incubation was carried out at 37°C for 15 min. Steroids were extracted and separated by t.l.c. as described previously (Liang & Heiss, 1981; Liang et al., 1984a Liang et al., , 1985a Fleischer & Kervina (1974) .
Other methods NADH:menadione reductase activity was assayed in a 3.0 ml reaction mixture containing rat liver microsomes (1 ,tg of protein), 0.2 mM-NADH, 1 mM-MgCl2, 10 mM-NaF, 1 mM-dithiothreitol, 0.6 mM-menadione and 50 mM-potassium phosphate, pH 7.0, in the presence or absence of y-linolenic acid. The reaction was carried out at 25°C and was monitored by the decrease in the absorbance at 340 nm (Liang et al., 1990 elaidic acid (C18: 1 trans-9), and linoleic acid (C18:2 cis-9,12) versus linolelaidic acid (C18:2, trans-9,12). The number and the position of the double bonds also affected the potency. For example, the inhibitory potencies of the C18 fatty acids were, in decreasing order: y-linolenic acid (cis-6,9, 12) > octadecatetraenoic acid (cis-6,9,12,15) > a-linolenic acid (cis-9,12,15) > linoleic acid (cis-9,12) > oleic acid (cis-9) > petroselinic acid (cis-6). Erucidic acid (C22: 1,cis-13) was inactive, whereas cis-4,7, 10,13,16,19- Compounds that showed less than 10 % inhibition were considered not active (NA). At 200 /SM, no significant effect was observed with (a) saturated aliphatic fatty acids, including caproic acid, heptanoic acid, caprylic acid, nonanoic acid, capric acid, undecanoic acid, lauric acid, tridecanoic acid, myristic acid, pentadecanoic acid, nonadecanoic acid, arachidic acid, heneicosanoic acid, behenic acid, tricosanoic acid and lignocenic acid, (b) fatty acyl esters and alcohols, including stearic acid methyl ester, S-stearoyl CoA, palmitic acid methyl ester, S-palmitoyl CoA, cis-9-tetradecenol and arachidonyl alcohol, and (c) vitamin A related compounds, including a-and fl-carotenes, retinoic acid, 9-cis-retinal, retinal and 1 3-cis-retinal.
At this high concentration, some aliphatic lipids showed inhibitory activities that were significantly lower than those of the corresponding unsaturated fatty acids (% inhibition in the parentheses): myristoleic acid methyl ester (27%), y-linolenic acid methyl ester (32%) and cis-4,7,10,13,16,19-docosahexaenol (51 % Fig. la ), but they were as potent as their cis isomers in the enzymic assay using either liver microsomes (Fig. b) or prostate microsomes (results not shown). Fig. 2 (Fig. 2) , inhibition was observed within 1 min after y-linolenic acid was mixed with the microsomal enzyme preparation, and was observed with both intact and detergent (polyoxyethylene ether)-solubilized rat liver microsomes (Fig. 3) .
As the concentrations of protein increased from 2 to 20 ,ug, the extent of inhibition by 10 lsM-y-linolenic acid decreased from 93 % to 52 % for intact microsomes and from 96 % to 88 % for solubilized microsomes. When remove free y-linolenic acid. The results showed that the inhibition was only partially reversed (reduced from 78 % to 63 % inhibition). It was possible that y-linolenic acid was bound tightly to microsomes and/or irreversibly inactivated components which were essential for the reductase activity.
By either the enzymic or the [3H]4-MA binding assay, the inhibition could not be overcome by increasing the level of NADPH or testosterone (Fig. 4) Table 2 shows that y-linolenic acid, at 5-50 gM, inhibited 5a-reduction of [3H]testosterone in both androgen-sensitive LNCaP cells and androgen-insensitive PC-3 cells. y-Linolenic acid, however, did not affect the metabolism of testosterone to 4-androstenedione, suggesting that 17,f-steroid dehydrogenase was not sensitive to this unsaturated fatty acid. Stearic acid (5-20 juM) did not affect the 5ac-reductase or 17fl-steroid dehydrogenase activities of PC-3 cells in culture.
Other microsomal enzymes and electron microscopic examination of microsomes glucuronic acid:5a-DHT glucuronosyltransferase (Table 3 ). (Lands, 1965) , the inhibitory activity may be due to non-conjugated unsaturated fatty acids. Further studies are necessary to determine the physiological significance of our findings in vitro. Since 5a-DHT stimulates sebum production and promotes acne, it is worth noting that lipids from the scalp of severe acne patients have been found to contain less linoleic acid than that of normal subjects (Morello et al., 1976) . The ability of y-linolenic acid to inhibit 5a-reductase in solubilized microsomes suggests that the y-linolenic acid inhibition may not be rigidly dependent on the native structure of endoplasmic reticulum membranes. Whether the fatty acid inhibitors act by interacting with the reductase and/or other components that are vital for reductase activity is not clear. The inhibitory fatty acids may also interact with and potentiate other endogenous inhibitors or lipids.
The proposed mechanism (Brandt et al., 1990) of Sa-reductase (E) reaction includes the following steps: (b) have been found (Liang & Heiss, 1981; Liang et al., 1984b Liang et al., , 1985b Brandt et al., 1990) .
A reductase gene coding for a 29 kDa polypeptide has been cloned from human (Anderson & Russell, 1990) and rat (Anderson et al., 1989) (Liang et al., 1985b) . The relationship between the 29 kDa unit and the 50 kDa form of 5a-reductase is not clear.
The stimulatory effect of certain phospholipids on 5a-reductase activity has been reported previously (Ichihara & Tanaka, 1987; Cooke & Robaire, 1985) . We also found that L-x-phosphatidylcholine and L-x-phosphatidylethanolamine can stimulate 5a-reductase. Phospholipids may affect the conformation of 5a-reductase. Whether unsaturated fatty acids can counteract the phospholipid stimulation is not known. Retinoic acid had been previously reported to inhibit 5a-reductase in the human prostate cancer cell PC-3 and in PC-3 cell homogenates (Halgunset et al., 1983) ; inhibition was shown to be competitive with NADPH.
We, however, found that retinoic acid at ,LM had no effect on 5a-reductase activity in rat liver microsomes. The reason for the discrepancy is not clear.
Polyunsaturated fatty acids can correct the effects of fatty acid deficiency that manifests as dermatitis, kidney necrosis, infertility and cardiovascular disease (Phillipson et al., 1985; Herold & Kinsella, 1986; Ziboh & Miller, 1990) and also can exhibit antitumour activities (Karmali et al., 1984; Begin, 1990) . Many unsaturated fatty acids are essential components of mammalian membranes, most of them are in the acylated form as triacylglycerols and phospholipids (Lands, 1965) . Arachidonic acid serves as a specific precursor in the biosynthesis of prostaglandins and leukotrienes (Needleman et al., 1986) . Several membrane-associated enzymes (5'-nucleotidase, acetyl-CoA carboxylase, glucose-6-phosphate dehydrogenase, etc.) have been shown to be affected by the polyunsaturated fatty acid content of the dietary fat, which changes the physicochemical properties of cellular membranes (Zuniga et al., 1989; Szepsesi et al., 1989) . Treatment of cerebral cortical slices (Baba et al., 1984) or intact retinas (Tesoriere et al., 1988) with unsaturated fatty acids can enhance adenylate cyclase activities, and various types of phospholipases in rat ventricular myocytes are modulated differentially by different unsaturated fatty acids in the culture medium (Nalbone et al., 1990) . Very few studies, however, have been carried out on the mode of action of non-esterified fatty acids on enzymes in cell-free systems. Certain cis-unsaturated fatty acids, at 50/M, were shown to stimulate protein kinase C activity (Dell & Severson, 1989) and inhibit steroid binding to receptors for androgens, oestrogens, glucocorticoids and progestins (Vallette et al., 1988; Kato, 1989) .
Clinical observations of patients with 5a-reductase deficiency (Imperato-McGinley et al., 1979) and studies of the effects of Sareductase inhibitors on experimental animals (Brooks et al., 1982; Liang et al., 1984a; George et al., 1989) have indicated that spermatogenesis, maintenance of libido, sex behaviour and feedback inhibition of gonadotropin secretion do not require the conversion of testosterone to 5a-DHT. Thus treatments of androgen-dependent skin and prostatic diseases by 5a-reductase inhibitors would be expected to produce fewer side-effects than the presently available hormonal therapies that involve castration and/or administration of oestrogens, androgen receptor antagonists (e.g. flutamide, spironolactone) or gonadotropinreleasing hormone superagonists (e.g. luprolide). In clinical studies, finasteride (a 4-azasteroid also known as MK906 or Proscar) that inhibits 5a-reductase by competing with testosterone (Liang et al., 1985a) , has been found to decrease the blood level of 5a-DHT and reduce prostate size (Vermeulen et al., 1989; Rittmaster et al., 1989; Gormley et al., 1990; ImperatoMcGinley et al., 1990) . Our identification of specific unsaturated fatty acids as potent inhibitors of Sa-reductase may lead to the design of new types of 5a-reductase inhibitors.
